What are the differences between an ovarian cyst, Meigs syndrome, and ovarian cancer?

Distinguishing Ovarian Cyst, Meigs Syndrome, and Ovarian Cancer

These are three distinct clinical entities that differ fundamentally in their pathology, presentation, and prognosis: ovarian cysts are benign fluid-filled structures that are extremely common and usually functional; Meigs syndrome is a rare triad of benign ovarian tumor (typically fibroma/thecoma), ascites, and pleural effusion that mimics malignancy; and ovarian cancer is a malignant neoplasm with the highest mortality of any gynecologic malignancy.

Ovarian Cysts

Definition and Characteristics

Ovarian cysts are fluid-filled sacs within or on the ovary surface. The vast majority in premenopausal women are functional cysts that resolve spontaneously 1.

Key Features

• Simple cysts (unilocular, thin-walled, anechoic) carry virtually no malignancy risk regardless of size or menopausal status 1
• Classic benign lesions include:
  • Hemorrhagic cysts (resolve in 8-12 weeks)
  • Endometriomas (ground-glass appearance, require yearly follow-up due to small malignancy risk)
  • Dermoid cysts/mature teratomas (contain fat, hair, teeth; <1% malignant transformation risk) 2, 1

Management Approach

• Premenopausal women: Simple cysts <5 cm require no follow-up 1
• Postmenopausal women: Purely fluid, thin-walled cysts >5 cm should be followed by ultrasound or excised—aspiration is contraindicated 3
• Risk of malignancy in sonographically benign-appearing lesions is <1% 1

Meigs Syndrome

Definition

A rare syndrome (occurs in ~1% of ovarian tumors) defined by the triad of:

1. Benign ovarian tumor (typically fibroma, thecoma, or fibrothecoma)
2. Ascites
3. Pleural effusion (usually right-sided) 4, 5

The Diagnostic Challenge

Meigs syndrome is notoriously difficult to distinguish from ovarian cancer preoperatively because:

• CA-125 levels are often markedly elevated (ranging 149-3803 IU/mL in reported cases) 5, 6
• Presents with solid ovarian mass, ascites, and pleural effusion—the classic presentation of advanced ovarian cancer
• Occurs predominantly in postmenopausal women 5, 6

Distinguishing Laboratory Features

Recent research identifies helpful differentiating markers 4:

• HE4 levels are lower in Meigs syndrome compared to ovarian cancer
• Lymphocyte counts are higher in Meigs syndrome than ovarian cancer
• Neutrophil-to-lymphocyte ratio (NLR) is lower in Meigs syndrome versus ovarian cancer
• Ascitic fluid is negative for malignant cells 6

Definitive Diagnosis and Outcome

• Surgical removal with histopathological examination is necessary for definitive diagnosis 5, 6
• Complete resolution of ascites and pleural effusion occurs rapidly after tumor removal
• CA-125 normalizes postoperatively (typically within weeks) 6
• Prognosis is excellent after surgical excision 5

Pseudo-Meigs Syndrome

When ascites and pleural effusion occur with a malignant ovarian tumor, this is termed pseudo-Meigs syndrome 7, 8. The clinical presentation is identical, but the underlying pathology is malignant.

Ovarian Cancer

Definition and Epidemiology

Malignant neoplasm of the ovary, representing the fifth leading cause of cancer death in women and causing more deaths than any other gynecologic malignancy 9.

Subtypes and Pathology

The 2020 WHO classification recognizes distinct subtypes 10:

• High-grade serous carcinoma (HGSC): 70% of cases, most aggressive
• Endometrioid carcinoma: 10%
• Clear cell carcinoma: 6-10%
• Low-grade serous carcinoma: 5%
• Mucinous carcinoma: 3-4%

Clinical Presentation

Early-stage disease (often asymptomatic or subtle):

• Irregular menses (premenopausal)
• Urinary frequency or constipation (from mass effect)
• Lower abdominal distention, pressure, dyspareunia 11

Advanced-stage disease (most common presentation—70% present at stage III/IV) 9:

• Abdominal distention and bloating from ascites
• Shortness of breath from pleural effusion
• Nausea, anorexia, early satiety
• Palpable inguinal, supraclavicular, or axillary lymph nodes 11

Diagnostic Features

Imaging characteristics highly suggestive of malignancy 11:

• Complex ovarian mass with both solid and cystic components
• Internal echoes and/or septations
• Ascites with peritoneal metastases
• Bilateral involvement common

CA-125 levels:

• Elevated in ~85% of advanced disease 10
• Only elevated in ~50% of stage I disease 9, 10
• False positives occur with endometriosis, pelvic inflammatory disease, menstruation, fibroids, benign cysts 11, 9
• Progressive elevation over time more specific for malignancy than single value 11

Additional markers:

• CEA and CA 19-9 for suspected mucinous tumors (CA-125/CEA ratio <25:1 suggests GI primary) 10
• AFP and β-hCG in young women to exclude germ cell tumors 3

Definitive Diagnosis

Surgical exploration with histopathological examination is necessary for confirmation and staging (except stage IV disease with pleural effusion or supraclavicular nodes) 3.

Fine-needle aspiration is contraindicated for solid or mixed ovarian masses due to risk of tumor spillage 3.

Critical Clinical Algorithm for Differentiation

Step 1: Ultrasound Characterization

• Simple, thin-walled, unilocular cyst → Benign ovarian cyst (no further workup needed if <5 cm in premenopausal women)
• Complex mass with solid components → Proceed to Step 2

Step 2: Clinical Context and Laboratory Assessment

• Measure CA-125, HE4, complete blood count with differential
• If CA-125 elevated with complex mass:
  • Lower HE4, higher lymphocytes, lower NLR → Consider Meigs syndrome
  • Higher HE4, lower lymphocytes, higher NLR → Suspect ovarian cancer 4

Step 3: Imaging Completion

• CT chest/abdomen/pelvis to assess for:
  • Peritoneal metastases (suggests cancer)
  • Pleural effusion pattern (right-sided more common in Meigs)
  • Lymphadenopathy (suggests cancer)

Step 4: Surgical Intervention

Both Meigs syndrome and ovarian cancer require surgery for definitive diagnosis—imaging and tumor markers cannot reliably distinguish them preoperatively 5, 6.

Common Pitfalls to Avoid

1. Do not assume elevated CA-125 equals cancer: Meigs syndrome commonly presents with CA-125 >1000 IU/mL 5, 6

2. Do not perform fine-needle aspiration of solid or complex ovarian masses—this is contraindicated and risks tumor spillage if malignant 3

3. Do not dismiss simple cysts as requiring follow-up in premenopausal women if <5 cm—these are universally benign 1

4. Do not forget to check ascitic fluid cytology when present—negative cytology supports Meigs syndrome over cancer 6

5. In postmenopausal women with complex mass, ascites, pleural effusion, and elevated CA-125, maintain high suspicion for malignancy but recognize Meigs syndrome as a diagnostic possibility requiring surgical confirmation 5, 6